• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

残疾与乳腺癌和宫颈癌筛查参与度:系统评价和荟萃分析。

Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis.

机构信息

Department of Public Health and Preventive Medicine, Faculty of Medicine, University of Mataram, Mataram 83125, Indonesia.

International Centre for Evidence in Disability, London School of Hygiene & Tropical Medicine, London WC1E 7HT, UK.

出版信息

Int J Environ Res Public Health. 2022 Aug 2;19(15):9465. doi: 10.3390/ijerph19159465.

DOI:10.3390/ijerph19159465
PMID:35954824
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9368105/
Abstract

It is well established that access to preventative care, such as breast or cervical cancer screening, can reduce morbidity and mortality. Certain groups may be missed out of these healthcare services, such as women with disabilities, as they face many access barriers due to underlying inequalities and negative attitudes. However, the data have not been reviewed on whether women with disabilities face inequalities in the uptake of these services. A systematic review and meta-analysis were conducted to compare the uptake of breast and cervical cancer screening in women with and without disabilities. A search was conducted in July 2021 across four databases: PubMed, MEDLINE, Global Health, and CINAHL. Quantitative studies comparing the uptake of breast or cervical cancer screening between women with and without disabilities were eligible. Twenty-nine studies were included, all from high-income settings. One third of the 29 studies (34.5%, 10) were deemed to have a high risk of bias, and the remainder a low risk of bias. The pooled estimates showed that women with disabilities have 0.78 (95% CI: 0.72-0.84) lower odds of attending breast cancer screening and have 0.63 (95% CI: 0.45-0.88) lower odds of attending cervical cancer screening, compared to women without disabilities. In conclusion, women with disabilities face disparities in receipt of preventative cancer care. There is consequently an urgent need to evaluate and improve the inclusivity of cancer screening programs and thereby prevent avoidable morbidity and mortality.

摘要

众所周知,获得预防保健服务,如乳腺癌或宫颈癌筛查,可以降低发病率和死亡率。某些群体可能会被这些医疗服务所忽视,例如残疾妇女,因为她们由于潜在的不平等和负面态度而面临许多获得服务的障碍。然而,尚未对残疾妇女在接受这些服务方面是否面临不平等进行审查。本研究进行了一项系统评价和荟萃分析,以比较有和无残疾妇女接受乳腺癌和宫颈癌筛查的情况。于 2021 年 7 月在四个数据库中进行了检索:PubMed、MEDLINE、全球健康和 CINAHL。纳入了比较有和无残疾妇女乳腺癌或宫颈癌筛查接受情况的定量研究。共纳入 29 项研究,均来自高收入环境。29 项研究中有 10 项(34.5%)被认为存在高偏倚风险,其余研究则存在低偏倚风险。汇总估计表明,与无残疾妇女相比,残疾妇女接受乳腺癌筛查的可能性低 0.78(95%CI:0.72-0.84),接受宫颈癌筛查的可能性低 0.63(95%CI:0.45-0.88)。总之,残疾妇女在获得预防癌症护理方面存在差异。因此,迫切需要评估和提高癌症筛查计划的包容性,从而预防可避免的发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/087ef7ad5b9c/ijerph-19-09465-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/e3b21dd9934c/ijerph-19-09465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/160e206b9855/ijerph-19-09465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/3eb742cf6cc3/ijerph-19-09465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/95db1d9b8b89/ijerph-19-09465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/8f9c04f74187/ijerph-19-09465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/087ef7ad5b9c/ijerph-19-09465-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/e3b21dd9934c/ijerph-19-09465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/160e206b9855/ijerph-19-09465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/3eb742cf6cc3/ijerph-19-09465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/95db1d9b8b89/ijerph-19-09465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/8f9c04f74187/ijerph-19-09465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bf27/9368105/087ef7ad5b9c/ijerph-19-09465-g006.jpg

相似文献

1
Disability and Participation in Breast and Cervical Cancer Screening: A Systematic Review and Meta-Analysis.残疾与乳腺癌和宫颈癌筛查参与度:系统评价和荟萃分析。
Int J Environ Res Public Health. 2022 Aug 2;19(15):9465. doi: 10.3390/ijerph19159465.
2
Interventions targeted at women to encourage the uptake of cervical screening.针对女性的干预措施,以鼓励她们接受宫颈癌筛查。
Cochrane Database Syst Rev. 2021 Sep 6;9(9):CD002834. doi: 10.1002/14651858.CD002834.pub3.
3
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
4
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
5
Prognostic factors for return to work in breast cancer survivors.乳腺癌幸存者恢复工作的预后因素。
Cochrane Database Syst Rev. 2025 May 7;5(5):CD015124. doi: 10.1002/14651858.CD015124.pub2.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.对携带BRCA1或BRCA2基因突变的女性进行降低风险的双侧输卵管卵巢切除术。
Cochrane Database Syst Rev. 2018 Aug 24;8(8):CD012464. doi: 10.1002/14651858.CD012464.pub2.
8
Personalised risk communication for informed decision making about taking screening tests.关于进行筛查测试的明智决策的个性化风险沟通。
Cochrane Database Syst Rev. 2006 Oct 18(4):CD001865. doi: 10.1002/14651858.CD001865.pub2.
9
The impact of screening on future health-promoting behaviours and health beliefs: a systematic review.筛查对未来健康促进行为和健康信念的影响:一项系统综述。
Health Technol Assess. 2003;7(42):1-92. doi: 10.3310/hta7420.
10
Bisphosphonates for breast cancer.用于乳腺癌的双膦酸盐类药物。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD003474. doi: 10.1002/14651858.CD003474.pub2.

引用本文的文献

1
Preventive Healthcare and Disability: Challenges and Opportunities.预防性医疗保健与残疾:挑战与机遇
Healthcare (Basel). 2025 Aug 23;13(17):2099. doi: 10.3390/healthcare13172099.
2
Understanding barriers to breast screening: an online survey of non-attenders as part of a service evaluation in the breast screening programme in England.了解乳腺癌筛查的障碍:对未参加者的在线调查,作为英格兰乳腺癌筛查计划服务评估的一部分。
BMC Public Health. 2025 Jul 19;25(1):2509. doi: 10.1186/s12889-025-23691-3.
3
Factors Determining Women's Attitudes and Knowledge Toward Breast Cancer Screening: A Systematic Review.

本文引用的文献

1
A systematic review of the barriers and facilitators influencing the cancer screening behaviour among people with intellectual disabilities.一项系统评价:影响智障人士癌症筛查行为的障碍和促进因素。
Cancer Epidemiol. 2022 Feb;76:102084. doi: 10.1016/j.canep.2021.102084. Epub 2021 Dec 15.
2
Comparison of colorectal cancer screening between people with and without disability: a nationwide matched cohort study.人群中有无残疾者的结直肠癌筛查比较:全国匹配队列研究。
BMC Public Health. 2021 Jun 2;21(1):1034. doi: 10.1186/s12889-021-11105-z.
3
Preventive Care Utilization among Adults with Hearing Loss in the United States.
决定女性对乳腺癌筛查态度和知识的因素:一项系统综述
Healthcare (Basel). 2025 Jul 4;13(13):1605. doi: 10.3390/healthcare13131605.
4
Functional Limitations and Use of General Health Examination and Cancer Screening Among People with Disabilities Who Need Support from Others: Secondary Data Analysis of the 2022 Comprehensive Survey of Living Conditions in Japan.需要他人支持的残疾人的功能限制以及一般健康检查和癌症筛查的使用情况:对2022年日本生活状况综合调查的二次数据分析
Int J Environ Res Public Health. 2025 Mar 24;22(4):484. doi: 10.3390/ijerph22040484.
5
Disability and Participation in Colorectal Cancer Screening: A Systematic Review and Meta-Analysis.结直肠癌筛查中的残疾与参与情况:系统评价和荟萃分析。
Curr Oncol. 2024 Nov 10;31(11):7023-7039. doi: 10.3390/curroncol31110517.
6
Factors Influencing Parental Decisions on HPV and Other Adolescent Vaccinations for Students with Intellectual Disability and/or Autism in New South Wales, Australia.澳大利亚新南威尔士州影响智障和/或自闭症学生家长对人乳头瘤病毒及其他青少年疫苗接种决策的因素
Vaccines (Basel). 2024 Aug 16;12(8):922. doi: 10.3390/vaccines12080922.
7
Sociodemographic inequalities in breast cancer screening attendance in Germany following the implementation of an Organized Screening Program: Scoping Review.德国实施有组织筛查计划后乳腺癌筛查参与的社会人口统计学不平等:范围综述。
BMC Public Health. 2024 Aug 14;24(1):2211. doi: 10.1186/s12889-024-19673-6.
8
Cervical screening participation and access facilitators and barriers for people with intellectual disability: a systematic review and meta-analysis.智障人士宫颈癌筛查参与情况及相关促进因素与障碍:一项系统评价和荟萃分析
Front Psychiatry. 2024 Jul 26;15:1379497. doi: 10.3389/fpsyt.2024.1379497. eCollection 2024.
9
A Systematic Review to Evaluate the Barriers to Breast Cancer Screening in Women with Disability.一项评估残疾女性乳腺癌筛查障碍的系统评价。
J Clin Med. 2024 Jun 2;13(11):3283. doi: 10.3390/jcm13113283.
10
To eliminate cervical cancer in Canada, nationwide funding of self-sampling for human papillomavirus is needed.为在加拿大消除宫颈癌,需要在全国范围内为人类乳头瘤病毒自我采样提供资金。
CMAJ. 2024 Jun 2;196(21):E729-E730. doi: 10.1503/cmaj.240722.
美国听力损失成年人的预防性保健利用情况
Semin Hear. 2021 Feb;42(1):37-46. doi: 10.1055/s-0041-1725999. Epub 2021 Apr 15.
4
MOOSE Reporting Guidelines for Meta-analyses of Observational Studies.观察性研究元分析的MOOSE报告指南。
JAMA Surg. 2021 Aug 1;156(8):787-788. doi: 10.1001/jamasurg.2021.0522.
5
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
6
Cancer Screening Among Adults With and Without Serious Mental Illness: A Mixed Methods Study.癌症筛查在患有和不患有严重精神疾病的成年人中的应用:一项混合方法研究。
Med Care. 2021 Apr 1;59(4):327-333. doi: 10.1097/MLR.0000000000001499.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
Disparities in Breast Cancer Screening Uptake for Women With Mental Illness in the United Kingdom.英国心理健康障碍女性乳腺癌筛查普及率的差异。
Am J Prev Med. 2021 Mar;60(3):e123-e130. doi: 10.1016/j.amepre.2020.09.010. Epub 2020 Dec 24.
9
Association of Vision Impairment With Preventive Care Use Among Older Adults in the United States.美国老年人视力障碍与预防保健利用的关联。
JAMA Ophthalmol. 2020 Dec 1;138(12):1298-1306. doi: 10.1001/jamaophthalmol.2020.4524.
10
Reduced Mammography Screening for Breast Cancer among Women with Visual Impairment.视力障碍女性的乳腺癌乳房 X 光筛查减少。
Ophthalmology. 2021 Feb;128(2):317-323. doi: 10.1016/j.ophtha.2020.07.029. Epub 2020 Jul 16.